JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2023. Vol. 68. № 1
DOI: 10.33266/1024-6177-2023-68-1-72-77
A.A. Lemaeva, I.A. Gulidov
Radiation Therapy and Pregnancy (Literature Review)
A.F. Tsyb Medical Radiological Research Centre, Obninsk, Russia
Contact person: A.A. Lemaeva, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
The possibility of radiation therapy during pregnancy remains a subject of discussion, in most cases, specialists try to avoid the use of radiation therapy in a pregnant woman. Currently, there is insufficient data confirming the safety of intrauterine radiation even with the use of modern methods of radiation therapy.
The purpose of this literature review is to summarize current clinical data on the appropriateness of the use and clinical results of the use of radiation therapy for the treatment of the most commonly diagnosed tumors in pregnant women.
Based on the literature data, it can be said that the possibility of using radiation therapy in the treatment of oncological diseases in pregnant women depends on the localization of the tumor, gestational age, the estimated total focal dose, the size of the irradiation field, the distance from the irradiation field to the fetus, the preferences of the patient.
Keywords: radiation therapy, pregnancy
For citation: Lemaeva AA, Gulidov IA. Radiation Therapy and Pregnancy (Literature Review). Medical Radiology and Radiation Safety. 2023;68(1):72–77. (In Russian). DOI: 10.33266/1024-6177-2023-68-1-72-77
References
1. Donegan W.L. Cancer and Pregnancy. CA Cancer J. Clin. 1983;33:194–214.
2. Hay A.E., Klimm B., Chen B.E., et al. An Individual Patient-Data Comparison of Combined Modality Therapy and ABVD Alone for Patients with Limited-Stage Hodgkin Lymphoma. Ann. Oncol. 2013;24:3065–3069.
3. Mazzola R., GiajLevra N., Alongi F. Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma. J. Clin. Oncol. 2016;34;24:2940–2941.
4. Perez C.A., Grigsby P.W., Chao K.S., et al. Tumor Size, Irradiation Dose, and Longterm Outcome of Carcinoma of Uterine Cervix. Int. J. Radiat. Oncol. Biol. Phys. 1998;41;2:307–317.
5. Corradini S., Niyazi M., Niemoeller O.M., et al. Adjuvant Radiotherapy after Breast Conserving Surgery – a Comparative Effectiveness Research Study. Radiother. Oncol. 2015;114;1:28–34.
6. Mazzola R., Ricchetti F., Fiorentino A., et al. Weekly Cisplatin and Volumetric Modulated Arc Therapy with Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results. Technology in Cancer Research & Treatment. 2017;16;3:310–315.
7. Nutting C.M., Morden J.P., Harrington K.J., et al. Parotid-Sparing Intensity Modulated Versus Conventional Radiotherapy in Head and Neck Cancer (PARSPORT): a Phase 3 Multicentrerandomised Controlled Trial. Lancet Oncol. 2011;12;2:127–136.
8. Mazzola R., Ferrera G., Alongi F., et al. Organ Sparing and Clinical Outcome with Step-and-Shoot IMRT for Head and Neck Cancer: a Mono-Institutional Experience. Radiol. Med. 2015;120;8:753–758.
9. GiajLevra N., Sicignano G., Fiorentino A., et al. Whole Brain Radiotherapy with Hippocampal Avoidance and Simultaneous Integrated Boost for Brain Metastases: a Dosimetric Volumetric-Modulated Arc Therapy Study. Radiol. Med. 2016;121;1:60–69.
10. Giaj-Levra N., Sciascia S., Fiorentino A., et al. Radiotherapy in Patients with Connective Tissue Diseases. Lancet Oncol. 2016;17;3:109–117.
11. Yoshimoto Y., Kato H., Schull W.J. Risk of Cancer among Children Exposed in Utero to A-Bomb Radiations. Lancet. 1988;2;8612:665–669.
12. Stovall M., Blackwell C.R., Cundiff J., et al. Fetal Dose from Radiotherapy with Photon Beams: Report of AAPM Radiation Therapy Committee Task Group No. 36. Medical Physics. 1995;22;1:63–82.
13. Nakagawa K., Aoki Y., Kusama T. Radiotherapy During Pregnancy: Effects on Fetuses and Neonates. Clinical Therapeutics. 1997;19:770–777.
14. Yonekura Y., Tsujii H., Hopewell, J.W., et al. International Commission on Radiological Protection. ICRP publication 127: Radiological Protection in Ion Beam Radiotherapy. Annals of the ICRP. 2014;43;4:5–113.
15. Otake M., Schull W.J. In Utero Exposure to A-Bomb Radiation and Mental Retardation: a Reassessment. The British Journal of Radiology. 1984;57: 409–414.
16. Miller R.W., Mulvihill J.J. Small Head Size after Atomic Irradiation. Teratology. 1976;14:355–358.
17. Mazzolaa R., Corradinib S., Eidemüeller M. Modern Radiotherapy in Cancer Treatment During Pregnancy. Critical Reviews in Oncology/Hematology. 2019;136:13-19.
18. Stewart A., Webb J., Giles D., et al. Malignant Disease in Childhood and Diagnostic Radiation in Utero. Lancet. 1956;1;271;6940:447.
19. Stewart A., Webb J., Hewitt D. A Survey of Childhood Malignancies. British Medical Journal. 1958;1;5086:1495–1508.
20. Bithell J.F., Draper G.J., Sorahan T., et al. Childhood Cancer Research in Oxford I: the Oxford Survey of Childhood Cancers. British Journal of Cancer. 2018;119;6:756–762.
21. Wakeford R., Little M.P. Risk Coefficients for Childhood Cancer after Intrauterine Irradiation: a Review. International Journal of Radiation Biology. 2003;79;5:293–309.
22. Chen Z., King W., Pearcey R., et al. The Relationship between Waiting Time for Radiotherapy and Clinical Outcomes: a Systematic Review of the Literature. Radiother Oncol. 2008;87;1:3–16.
23. Antypas C., Sandilos P., Kouvaris J., et al. Fetal Dose Evaluation During Breast Cancer Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1998;1;40;4:995–999.
24. Ngu S.L., Duval P., Collins C. Foetal Radiation Dose in Radiotherapy for Breast Cancer. Aust. Radiol. 1992;36;4:321–322.
25. Van der Giessen P.H. Measurement of the Peripheral Dose for the Tangential Breast Treatment Technique with Co-60 Gamma Radiation and High Energy X-Rays. Radiother. Oncol. 1997;42;3:257–264.
26. Antolak J.A., Strom E.A. Fetal Dose Estimates for Electron-Beam Treatment to the Chest Wall of a Pregnant Patient. Med. Phys. 1998;25;12:2388–2391.
27. Van Calsteren K., Heyns L., De Smet, F., et al. Cancer During Pregnancy: an Analysis of 215 Patients Emphasizing the Obstetrical and the Neonatal Outcomes. J. Clin. Oncol. 2010;28;4:683–689.
28. Suwanbut P., Liamsuwan T., Nantajit D., Masa-Nga W., et al. Assessment of Fetal Dose and Health Effect to the Fetus from Breast Cancer Radiotherapy During Pregnancy. Life (Basel). 2022;12;1:84.
29. Galimberti V., Ciocca M., Leonardi M.C., et al. Is Electron Beam Intraoperative Radiotherapy (ELIOT) Safe in Pregnant Women with Early Breast Cancer? In Vivo Dosimetry to Assess Fetal Dose. Ann. Surg. Oncol. 2009;16;1:100–105.
30. Leonardi M., Cecconi A., Luraschi R., et al. Electron Beam Intraoperative Radiotherapy (ELIOT) in Pregnant Women with Breast Cancer: from in Vivo Dosimetry to Clinical Practice. Breast Care (Basel). 2017;12;6:396–400.
31. Amant F., Deckers S., Van Calsteren K., et al. Breast Cancer in Pregnancy: Recommendations of an International Consensus Meeting. Eur. J. Cancer. 2010;46;18:3158–3168.
32. Amouzegar Hashemi F. Radiotherapy in Pregnancy-Associated Breast Cancer. Advances in Experimental Medicine and Biology. 2020;1252:125-127.
33. Gustaffson D.C., Kottmeier H.L. Carcinoma of the Cervix Associated with Pregnancy. A Study of the Radiumhemmet’s Series of Invasive Carcinoma During the Period 1932-1956. Acta Obstet. Gynecol. Scand. 1962;41:1–21.
34. Prem K.A., Makowski E.L., McKelvey J.L. Carcinoma of the Cervix Associated with Pregnancy. Am. J. Obstet. Gynecol. 1966;95;1:99–108.
35. Hunter M.I., Tewari K., Monk B.J. Cervical Neoplasia in Pregnancy. Part 2: Current Treatment of Invasive Disease. Am. J. Obstet. Gynecol. 2008;199:10–18.
36. Sood A.K., Sorosky J.I., Mayr N., et al. Radiotherapeutic Management of Cervical Carcinoma that Complicates Pregnancy. Cancer. 1997;80;6:1073–1078.
37. Woo S.Y., Fuller L.M., Cundiff J.H., et al. Radiotherapy During Pregnancy for Clinical Stages IA-IIA Hodgkin’s Disease. Int. J. Radiat. Oncol. Biol. Phys. 1992;23;2:407–412.
38. Lishner M., Zemlickis D., Degendorfer P., et al. Maternal and Foetal Outcome Following Hodgkin’s Disease in Pregnancy. Br. J. Cancer. 1992;65;1:114–117.
39. Evens A.M., Advani R., Press O.W., et al. Lymphoma Occurring During Pregnancy: Antenatal Therapy, Complications, and Maternal Survival in a Multicenter Analysis. J. Clin. Oncol. 2013;31;32:4132–4139.
40. Haba Y., Twyman N., Thomas SJ., et al. Radiotherapy for Glioma During Pregnancy: Fetal Dose Estimates, Risk Assessment and Clinical Management. Clin. Oncol. (R Coll Radiol). 2004;16:210–214.
41. Mazonakis M., Damilakis J., Theoharopoulos N., et al. Brain Radiotherapy During Pregnancy: an Analysis of Conceptus Dose Using Anthropomorphic Phantoms. Br. J. Radiol. 1999;72:274–278.
42. Podgorsak M., Meiler R., Kowal H., et al. Technical Management of a Pregnant Patient Undergoing Radiation Therapy to the Head and Neck. Med. Dosim. 1999;24;2:121-128.
43. Nuyttens J.J., Prado K.L., Jenrette J.M., Williams T.E. Fetal Dose During Radiotherapy: Clinical Implementation and Review of the Literature. Cancer Radiother. 2002;6:352–357.
44. Sharma D.S., Jalali R., Tambe C.M., et al. Effect of Tertiary Multileaf Collimator (MLC) on Foetal Dose During Three-Dimensional Conformal Radiation Therapy (3DCRT) of a Brain Tumour During Pregnancy. Radiother Oncol. 2004;70:49–54.
45. Yu C., Jozsef G., Apuzzo ML, et al. Fetal Radiation Doses for Model C Gamma Knife Radiosurgery. Neurosurgery. 2003;52:687–693.
46. Magné N., Marcié S., Pignol J.P., et al. Radiotherapy for a Solitary Brain Metastasis During Pregnancy: a Method for Redu-
cing Fetal Dose. Br. J. Radiol. 2001;74:638–641.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.09.2022. Accepted for publication: 25.11.2022.